Cargando…
Correction: The genetic consequences of dog breed formation—Accumulation of deleterious genetic variation and fixation of mutations associated with myxomatous mitral valve disease in cavalier King Charles spaniels
Autores principales: | Axelsson, Erik, Ljungvall, Ingrid, Bhoumik, Priyasma, Conn, Laura Bas, Muren, Eva, Ohlsson, Åsa, Olsen, Lisbeth Høier, Engdahl, Karolina, Hagman, Ragnvi, Hanson, Jeanette, Kryvokhyzha, Dmytro, Pettersson, Mats, Grenet, Olivier, Moggs, Jonathan, Rio-Espinola, Alberto Del, Epe, Christian, Taillon, Bruce, Tawari, Nilesh, Mane, Shrinivas, Hawkins, Troy, Hedhammar, Åke, Gruet, Philippe, Häggström, Jens, Lindblad-Toh, Kerstin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794096/ https://www.ncbi.nlm.nih.gov/pubmed/35085237 http://dx.doi.org/10.1371/journal.pgen.1010039 |
Ejemplares similares
-
The genetic consequences of dog breed formation—Accumulation of deleterious genetic variation and fixation of mutations associated with myxomatous mitral valve disease in cavalier King Charles spaniels
por: Axelsson, Erik, et al.
Publicado: (2021) -
Genetic Variants at the Nebulette Locus Are Associated with Myxomatous Mitral Valve Disease Severity in Cavalier King Charles Spaniels
por: Mead, Sophie E., et al.
Publicado: (2022) -
A Genomic Study of Myxomatous Mitral Valve Disease in Cavalier King Charles Spaniels
por: Bionda, Arianna, et al.
Publicado: (2020) -
Comparative transcriptomic profiling of myxomatous mitral valve disease in the cavalier King Charles spaniel
por: Markby, G. R., et al.
Publicado: (2020) -
Pharmacokinetics of Repeated Oral Dosing with Coenzyme Q10 in Cavalier King Charles Spaniels with Myxomatous Mitral Valve Disease
por: Christiansen, Liselotte B., et al.
Publicado: (2020)